Literature DB >> 1469181

Low dose amiodarone pulmonary toxicity in a patient with a history of pneumonectomy.

H van der Zeyden1, D Zandstra, M van Hengstum.   

Abstract

A case of amiodarone pulmonary toxicity (APT) is described following a low dosage of amiodarone (200 mg/day) with serious respiratory insufficiency in a patient after right pneumonectomy. The patient was successfully treated by discontinuation of amiodarone, mechanical ventilation and prednisolone (40 mg/day). A literature study indicates that APT is a dose related toxicity. In our opinion a higher pulmonary drug concentration of amiodarone could exist from a change in pharmacokinetics because of a low fat storage in a thin patient and compensatory growth of the remaining lung which occurs after pneumonectomy. Given these findings we suggest that if amiodarone is indicated in such patients both loading and maintenance doses should be adapted.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1469181     DOI: 10.1007/bf01694345

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  9 in total

Review 1.  Postpneumonectomy compensatory lung growth.

Authors:  P T Cagle; W M Thurlbeck
Journal:  Am Rev Respir Dis       Date:  1988-11

Review 2.  Mechanisms of amiodarone pulmonary toxicity.

Authors:  W J Martin
Journal:  Clin Chest Med       Date:  1990-03       Impact factor: 2.878

3.  Pulmonary accumulation of amiodarone and N-desethylamiodarone. Relationship to the development of pulmonary toxicity.

Authors:  B D Wilson; M L Lippmann
Journal:  Am Rev Respir Dis       Date:  1990-06

4.  Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.

Authors:  S M Sobol; L Rakita
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

5.  Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity.

Authors:  P T Pollak; A D Sharma; S G Carruthers
Journal:  Am J Cardiol       Date:  1990-05-15       Impact factor: 2.778

6.  Pulmonary gallium-67 uptake in amiodarone pneumonitis.

Authors:  W J van Rooij; S C van der Meer; E A van Royen; N van Zandwijk; J I Darmanata
Journal:  J Nucl Med       Date:  1984-02       Impact factor: 10.057

Review 7.  Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).

Authors:  W J Martin; E C Rosenow
Journal:  Chest       Date:  1988-05       Impact factor: 9.410

8.  [Pneumonitis following amiodarone therapy].

Authors:  L Denis; I Reymen; P Cleeren
Journal:  J Belge Radiol       Date:  1989-04

9.  Amiodarone pulmonary toxicity: prospective evaluation of serial pulmonary function tests.

Authors:  S A Magro; E C Lawrence; S H Wheeler; J Krafchek; H T Lin; C R Wyndham
Journal:  J Am Coll Cardiol       Date:  1988-09       Impact factor: 24.094

  9 in total
  1 in total

Review 1.  Amiodarone-induced pulmonary toxicity. Predisposing factors, clinical symptoms and treatment.

Authors:  G A Jessurun; W G Boersma; H J Crijns
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.